Top

Supportive Care in Cancer

Published in:

01-09-2019 | Anxiety | Original Article

Fear of disease progression in adult ambulatory patients with brain cancer: prevalence and clinical correlates

Authors: Simone Goebel, Hubertus Maximilian Mehdorn

Published in: Supportive Care in Cancer | Issue 9/2019

Abstract

Background

Fear of progression (FoP) is frequent in patients with cancer and of high clinical relevance. Despite the often devastating prognosis of brain cancer, FoP has not yet been assessed in neurooncological patients.

Objective

The aim of this study was thus the assessment of FoP and its clinical correlates.

Methods

In an ambulatory setting, 42 patients with a primary brain tumour completed the Fear of Progression questionnaire FoP-Q-12. Clinical correlates of FoP were assessed via a variety of measures, including patients’ physical state (Karnofsky Performance Status, KPS), cancer-related psychosocial distress (Distress Thermometer, DT), anxiety (General Anxiety Disorder Scale, GAD-7), depression (Patient Health Questionnaire, PHQ-9), Quality of Life (Short Form Health Survey, SF-8), and unmet supportive care needs (Supportive Care Needs Survey, SCNS).

Results

Eighteen patients (42%) suffered from high FoP (i.e. scored ≥ 34 in the FoP-Q-12). According to the 12 items of the FoP-Q-12, the greatest fears were worrying about what would happen to their family and being afraid of severe medical treatments. No sociodemographic variables (e.g. age, gender) or medical tumour characteristics (e.g. tumour malignancy, first or recurrent tumour) were related to FoP. Patients with more severe physical symptoms reported higher FoP. Patients with higher FoP were more anxious, more depressed, reported lower Quality of Life, and suffered from more unmet supportive care needs.

Conclusion

Our results demonstrate that FoP is frequent and of high clinical relevance for neurooncological patients. Its assessment is not sufficiently covered by instruments for assessment of other areas of psychological morbidity (e.g. general anxiety). Moreover, FoP cannot be predicted by objective characteristics of the patients and disease. Thus, the routine screening for FoP is recommended in neurooncological patients. Clinicians should bear in mind that patients with high FoP are likely to suffer from high emotional distress and unmet supportive care needs and initiate treatment accordingly.

de Robles P, Fiest KM, Frolkis AD, Pringsheim T, Atta C, St. Germaine-Smith C, Day L, Lam D, Jette N (2015) The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis. Neuro-Oncology 17:776–783. https://doi.org/10.1093/neuonc/nou283 CrossRefPubMed

Ownsworth T, Hawkes A, Steginga S, Walker D, Shum D (2009) A biopsychosocial perspective on adjustment and quality of life following brain tumor. Disabil Rehabil 31:1038–1055. https://doi.org/10.1080/09638280802509538 CrossRefPubMed

Ostrom QT, Gittleman H, Fulop J et al (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro-Oncology 17(Suppl 4):iv1–iv62. https://doi.org/10.1093/neuonc/nov189 CrossRefPubMedPubMedCentral

Chochinov HM (2001) Depression in cancer patients. Lancet Oncol 2:499–505. https://doi.org/10.1016/S1470-2045(01)00456-9 CrossRefPubMed

Huang J, Zeng C, Xiao J, Zhao D, Tang H, Wu H, Chen J (2017) Association between depression and brain tumor: a systematic review and meta-analysis. Oncotarget 8:94932–94943. https://doi.org/10.18632/oncotarget.19843 CrossRefPubMedPubMedCentral

Huang ME, Wartella J, Kreutzer J, Broaddus W, Lyckholm L (2001) Functional outcomes and quality of life in patients with brain tumours: a review of the literature. Brain Inj 15(10):843–856. https://doi.org/10.1080/02699050010013653 CrossRefPubMed

Goebel S, Stark AM, Kaup L, von Harscher M, Mehdorn HM (2011) Distress in patients with newly diagnosed brain tumours. Psycho-Oncology 20:623–630. https://doi.org/10.1002/pon.1958 CrossRefPubMed

Pace A, Metro G, Fabi A (2010) Supportive care in neurooncology. Curr Opin Oncol 22:621–626. https://doi.org/10.1097/CCO.0b013e32833e078c CrossRefPubMed

Salander P (2010) Facilitating interventions and/or relationships in malignant brain tumors. Adv Ther 27:17–27. https://doi.org/10.1007/s12325-010-0003-z CrossRefPubMed

10.

Berg P, Book K, Dinkel A, Henrich G, Marten-Mittag B, Mertens D, Ossner C, Volmer S, Herschbach P (2011) Progredienzangst bei chronischen Erkrankungen. Psychother Psychosom Med Psychol 61:32–37. https://doi.org/10.1055/s-0030-1267927 CrossRefPubMed

11.

Dankert A, Duran G, Engst-Hastreiter U et al (2003) Progredienzangst bei Patienten mit Tumorerkrankungen, Diabetes mellitus und entzündlich-rheumatischen Erkrankungen. Rehabilitation 42:155–163. https://doi.org/10.1055/s-2003-40094 CrossRefPubMed

12.

Herschbach P, Dinkel A (2014) Fear of progression. In: Goerling U (ed) Psycho-Oncology. Springer, Berlin s.l, pp 11–29CrossRef

13.

Herschbach P, Berg P, Dankert A, Duran G, Engst-Hastreiter U, Waadt S, Keller M, Ukat R, Henrich G (2005) Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire. J Psychosom Res 58:505–511. https://doi.org/10.1016/j.jpsychores.2005.02.007 CrossRef

14.

Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, Ozakinci G (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 7:300–322. https://doi.org/10.1007/s11764-013-0272-z CrossRefPubMed

15.

Koch L, Jansen L, Brenner H, Arndt V (2013) Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors- a systematic review of quantitative studies. Psycho-Oncology 22(1):1–11. https://doi.org/10.1002/pon.3022 CrossRefPubMed

16.

Lebel S, Tomei C, Feldstain A, Beattie S, McCallum M (2013) Does fear of cancer recurrence predict cancer survivors' health care use? Support Care Cancer 21:901–906. https://doi.org/10.1007/s00520-012-1685-3 CrossRefPubMed

17.

Mehnert A, Berg P, Henrich G, Herschbach P (2009) Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psycho-Oncology 18:1273–1280. https://doi.org/10.1002/pon.1481 CrossRefPubMed

18.

Sarkar S, Scherwath A, Schirmer L, Schulz-Kindermann F, Neumann K, Kruse M, Dinkel A, Kunze S, Balck F, Kröger N, Koch U, Mehnert A (2014) Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT. Bone Marrow Transplant 49:1217–1222. https://doi.org/10.1038/bmt.2014.139 CrossRefPubMed

19.

Mehnert A, Koch U, Sundermann C et al (2013) Predictors of fear of recurrence in patients one year after cancer rehabilitation: a prospective study. Acta Oncol (Stockholm, Sweden) 52:1102–1109. https://doi.org/10.3109/0284186X.2013.765063 CrossRef

20.

Hall DL, Luberto CM, Philpotts LL, Song R, Park ER, Yeh GY (2018) Mind-body interventions for fear of cancer recurrence: a systematic review and meta-analysis. Psycho-Oncology 27:2546–2558. https://doi.org/10.1002/pon.4757 CrossRefPubMedPubMedCentral

21.

Berrett-Abebe J, Cadet T, Pirl W, Lennes I (2015) Exploring the relationship between fear of cancer recurrence and sleep quality in cancer survivors. J Psychosoc Oncol 33:297–309. https://doi.org/10.1080/07347332.2015.1020586 CrossRefPubMed

22.

Sarkar S, Sautier L, Schilling G, Bokemeyer C, Koch U, Mehnert A (2015) Anxiety and fear of cancer recurrence and its association with supportive care needs and health-care service utilization in cancer patients. J Cancer Surviv 9:567–575. https://doi.org/10.1007/s11764-015-0434-2 CrossRefPubMed

23.

Crist JV, Grunfeld EA (2013) Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psycho-Oncology 22:978–986. https://doi.org/10.1002/pon.3114 CrossRefPubMed

24.

Champagne A, Ivers H, Savard J (2018) Utilization of health care services in cancer patients with elevated fear of cancer recurrence. Psycho-Oncology 27:1958–1964. https://doi.org/10.1002/pon.4748 CrossRefPubMed

25.

Shim E-J, Shin Y-W, Oh D-Y, Hahm BJ (2010) Increased fear of progression in cancer patients with recurrence. Gen Hosp Psychiatry 32:169–175. https://doi.org/10.1016/j.genhosppsych.2009.11.017 CrossRefPubMed

26.

Mehnert A, Herschbach P, Berg P, Henrich G, Koch U (2006) Fear of progression in breast cancer patients – validation of the short form of the fear of progression questionnaire (FoP-Q-SF). Z Psychosom Med Psychother 52:274–288. https://doi.org/10.13109/zptm.2006.52.3.274 CrossRefPubMed

27.

Mehnert A, Müller D, Lehmann C, Koch U (2006) Die deutsche Version des NCCN Distress-Thermometers. Z Psychiatr Psychol Psychother 54:213–223. https://doi.org/10.1024/1661-4747.54.3.213 CrossRef

28.

National Comprehensive Cancer Network (NCCN) (2003) Distress management. Clinical practice guidelines. J Natl Compr Cancer Netw 1:344–374CrossRef

29.

Spitzer RL, Kroenke K, Williams JBW, Löwe B (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166:1092–1097. https://doi.org/10.1001/archinte.166.10.1092 CrossRefPubMed

30.

Löwe B, Decker O, Müller S, Brähler E, Schellberg D, Herzog W, Herzberg PY (2008) Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care 46:266–274. https://doi.org/10.1097/MLR.0b013e318160d093 CrossRefPubMed

31.

Löwe B, Spitzer RL, Zipfel S, Herzog W (2000) Der Gesundheitsfragebogen für Patienten (PHQ-D). Manual und Testunterlagen

32.

Spitzer RL (1999) Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA 282:1737. https://doi.org/10.1001/jama.282.18.1737 CrossRef

33.

Ware JE, Kosinski M, Dewey JE, Gandek B, Ware JE, Kisinski M, Ware J, Dewey J (2008) How to score and interpret single-item health status measures. A manual for users of the SF-8™ Health Survey

34.

Bonevski B, Sanson-Fisher R, Girgis A, Burton L, Cook P, Boyes A, the Supportive Care Review Group (2000) Evaluation of an instrument to assess the needs of patients with cancer. Cancer 88:217–225. https://doi.org/10.1002/(SICI)1097-0142(20000101)88:1<217:AID-CNCR29>3.0.CO;2-Y CrossRefPubMed

35.

Hinz A, Mehnert A, Ernst J, Herschbach P, Schulte T (2015) Fear of progression in patients 6 months after cancer rehabilitation- a validation study of the fear of progression questionnaire FoP-Q-12. Support Care Cancer 23:1579–1587. https://doi.org/10.1007/s00520-014-2516-5 CrossRefPubMed

36.

Hanprasertpong J, Geater A, Jiamset I, Padungkul L, Hirunkajonpan P, Songhong N (2017) Fear of cancer recurrence and its predictors among cervical cancer survivors. J Gynecol Oncol 28:e72. https://doi.org/10.3802/jgo.2017.28.e72 CrossRefPubMedPubMedCentral

37.

Goebel S, Kaup L, Mehdorn HM (2011) Measuring preoperative anxiety in patients with intracranial tumors: the Amsterdam preoperative anxiety and information scale. J Neurosurg Anesthesiol 23:297–303. https://doi.org/10.1097/ANA.0b013e318222b787 CrossRefPubMed

38.

Goebel S, Mederer D, Mehdorn HM (2018) Surgery-related coping in surgery patients with intracranial tumors. World Neurosurg 116:e775–e782. https://doi.org/10.1016/j.wneu.2018.05.091 CrossRefPubMed

39.

Goebel S, Strenge H, Mehdorn HM (2012) Acute stress in patients with brain cancer during primary care. Support Care Cancer 20(7):1425–1434. https://doi.org/10.1007/s00520-011-1225-6 CrossRefPubMed

40.

Sharpe L, Curran L, Butow P, Thewes B (2018) Fear of cancer recurrence and death anxiety. Psycho-Oncology 27:2559–2565. https://doi.org/10.1002/pon.4783 CrossRefPubMed

41.

Salander P (1996) Brain tumor as a threat to life and personality. J Psychosoc Oncol 14:1–18. https://doi.org/10.1300/J077v14n03_01 CrossRef

42.

Cohee AA, Adams RN, Johns SA, von Ah D, Zoppi K, Fife B, Monahan PO, Stump T, Cella D, Champion VL (2017) Long-term fear of recurrence in young breast cancer survivors and partners. Psycho-Oncology 26:22–28. https://doi.org/10.1002/pon.4008 CrossRefPubMed

43.

Ganz PA, Kwan L, Stanton AL, Krupnick JL, Rowland JH, Meyerowitz BE, Bower JE, Belin TR (2004) Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst 96:376–387CrossRefPubMed

44.

Zimmermann T, Herschbach P, Wessarges M et al (2011) Fear of progression in partners of chronically ill patients. Behav Med (Washington, D.C.) 37:95–104. https://doi.org/10.1080/08964289.2011.605399 CrossRef

45.

Mellon S, Kershaw TS, Northouse LL, Freeman-Gibb L (2007) A family-based model to predict fear of recurrence for cancer survivors and their caregivers. Psycho-Oncology 16:214–223. https://doi.org/10.1002/pon.1074 CrossRefPubMed

Title: Fear of disease progression in adult ambulatory patients with brain cancer: prevalence and clinical correlates
Authors: Simone Goebel
Hubertus Maximilian Mehdorn
Publication date: 01-09-2019
Publisher: Springer Berlin Heidelberg
Keyword: Anxiety
Published in: Supportive Care in Cancer / Issue 9/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-019-04665-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 9/2019

Management of anticoagulation in patients with metastatic castration–resistant prostate cancer receiving abiraterone + prednisone

Cognitive rehabilitation for cancer-related cognitive dysfunction: a systematic review

Managing malignant pleural mesothelioma: experience and perceptions of health care professionals caring for people with mesothelioma

Are cancer helplines effective in supporting caregivers? A systematic review

Respectful encounters from healthcare professionals and return to work among 9032 long-term sick-listed due to cancer or due to other diagnoses: results from a Swedish population-based survey

Need and demand for nutritional counselling and their association with quality of life, nutritional status and eating-related distress among patients with cancer receiving outpatient chemotherapy: a cross-sectional study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer